HIGHLIGHTS
- who: Sara Piccini from the function, improved cardiac function under conditions of coronary ischemia, anti-inflammatory, and anti-atherosclerotic effects [16]The first , RA to be approved in Italy have published the Article: Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study, in the Journal: (JOURNAL)
- what: The institutional Ethical Committee approved this study and patients gave standard written informed consent to use their anonymized clinical data for research purposes. Strengths of this study include the relatively long follow-up period, compared to most CVOTs and real-world studies . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.